XCE Tirzepatide is a high-purity white powder compound with CAS number 2023788-19-2, designed specifically for research applications. This dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist demonstrates superior efficacy in glucose control and weight management studies compared to selective GLP-1 receptor agonists.
The molecular formula of XCE Tirzepatide is C225H348N48O68, with a molecular weight of 4813. Our product is available in multiple concentrations ranging from 5mg to 45mg per vial, packaged in sets of 10 vials to accommodate various research requirements.
As a dual receptor agonist, XCE Tirzepatide exhibits greater affinity for GIP receptors than GLP-1 receptors, making it particularly valuable for metabolic disorder research. The compound has shown promising results in studies related to type 2 diabetes management and associated metabolic conditions.
Our XCE Tirzepatide is manufactured under strict quality control standards to ensure 99% purity. The product is supplied as a lyophilized white powder, carefully packaged to maintain stability and potency throughout the research process.
Important Note: This product is intended for laboratory research purposes only. Not for human consumption or diagnostic use. Proper safety protocols should always be followed when handling research compounds.